Search clinical trials for: GERD

Total 681 results

Janssen-Ortho Inc., Canada

Completed

A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole

GERD
National Taiwan University Hospital

Completed

CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing

GERD

Taiwan
McMaster University
St. Joseph's Healthcare Hamilton

Completed

A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD

Gastroesophageal Reflux

Canada
AstraZeneca

Completed

Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)

Sensitivity in Esophagus

Denmark, Sweden
Midwest Biomedical Research Foundation
Medical University of South Carolina; Academisch Medisch Centrum - Universiteit... and other collaborators

Completed

Novel Imaging Techniques in Barrett's Esophagus

Gastroesophageal Reflux | Barrett Esophagus

United States, Netherlands
Midwest Biomedical Research Foundation
Kansas City Veteran Affairs Medical Center

Withdrawn

A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients

Gastroesophageal Reflux Disease

United States
Assistance Publique - Hôpitaux de Paris

Completed

Optimal Dosing of Omeprazole in Neonates (OMEPRAZOLE-1)

Gastroesophageal Reflux Disease (GERD)

France
Yvonne Romero
Bausch Health Americas, Inc.

Completed

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

Erosive Esophagitis

United States
Carle Physician Group

Terminated

Domperidone for Relief of Gastrointestinal Disorders

Dyspepsia | Nausea | Vomiting | Esophagitis | GERD | Chronic Idiopathic Constipation | Gastroparesis

United States
University of Zurich

Completed

Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients

Gastroesophageal Reflux Disease | Healthy Volunteers

Switzerland
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Withdrawn

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Head and Neck Cancer | Gastroesophageal Reflux Disease | Oropharyngeal Cancer
Takeda

Completed

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Gastroesophageal Reflux
University of South Florida

Unknown

Assessing Outcomes After Surgery for Gastroesophageal Reflux Disorder (GERD)

Gastroesophageal Reflux Disorder

United States
Vecta Ltd.

Completed

Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

Gastroesophageal Reflux

United States
Addex Pharma S.A.

Completed

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

United States, France, Germany, Netherlands, Switzerland
University of Iowa

Withdrawn

Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain (Dexilant)

Chest Pain | Gastrointestinal Reflux Disease

United States
Song Kyung Ho

Unknown

Prevalence of Gastroesophageal Reflux Disease in Peritoneal Dialysis and Hemodialysis Patients

Gastroesophageal Reflux Disease

Korea, Republic of
Takeda

Completed

Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease (PAMES 0109)

GERD

Brazil
GlaxoSmithKline

Completed

Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.

Reflux, Gastroesophageal | Gastroesophageal Reflux Disease

Australia
AstraZeneca

Completed

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Bulgaria
Nycomed

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease (PARADE)

Gastroesophageal Reflux Disease

Germany
Takeda

Completed

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

Gastroesophageal Reflux | GERD | GORD

United Kingdom
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

Gastroesophageal Reflux

Germany
Takeda

Completed

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

GERD

Hungary, Austria, Germany, Australia
Takeda

Terminated

The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)

Gastroesophageal Reflux Disease | Non-erosive Reflux Disease

Switzerland, Netherlands
Takeda

Completed

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

Gastroesophageal Reflux Disease (GERD)

United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
Takeda

Completed

Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)

Gastroesophageal Reflux Disease (GERD) | Peptic Ulcers

Germany
Takeda

Completed

Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)

Gastroesophageal Reflux Disease

Germany, Poland, Brazil, South Africa
Mayo Clinic

Withdrawn

Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis

Gastroesophageal Reflux Disease | Dysphagia | Eosinophilic Esophagitis
Eisai Co., Ltd.

Completed

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

Refractory Reflux Esophagitis

Japan
AstraZeneca

Completed

The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

Gastroesophageal Reflux Disease

Bosnia and Herzegovina
Institut National de la Santé Et de la Recherche...
Fondation de l'Avenir

Unknown

Combined tDCS+PNS After Acute Stroke

Acute Ischaemic Stroke

France
Children's Hospital of Philadelphia

Withdrawn

A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux

Laryngopharyngeal Reflux

United States
arpa pungrasamee

Completed

Detection of Minimal Change Esophagitis by I-scan

Non-erosive Reflux Disease | Gastro-esophageal Reflux Disease

Thailand
Seoul National University Hospital

Unknown

Adipokines and the Risk of Reflux Esophagitis

Visceral Obesity | Reflux Esophagitis

Korea, Republic of
Forest Laboratories

Completed

The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

Dyspepsia

United States
David A. Johnson, MD
AstraZeneca

Completed

Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

GERD

United States
Seoul National University Bundang Hospital

Completed

Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life

Non-erosive Reflux Disease (NERD) | Reflux Esophagitis (RE) | Functional Heartburn (FH)

Korea, Republic of
Takeda

Completed

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Gastroesophageal Reflux

United States
Takeda

Completed

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Gastroesophageal Reflux

United States
AstraZeneca

Completed

Impact of GERD on Daily Life (NIS) (Alegria)

GERD

Belgium
Swedish Medical Center

Completed

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

Gastroesophageal Reflux | Gastroesophageal Reflux Disease | GERD | Esophageal Reflux

United States
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

GERD | Erosive Esophagitis

Korea, Republic of
University of North Carolina, Chapel Hill
AstraZeneca

Completed

The Utility of Nexium in Chronic Cough and Reflux Disease

Cough | GERD

United States
University of North Carolina, Chapel Hill
Takeda Pharmaceuticals North America, Inc.

Completed

Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease

Overweight | Gastroesophageal Reflux Disease | Acid Reflux Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Children With GERD

Gastroesophageal Reflux

United States
Astellas Pharma Inc

Completed

Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease

Gastroesophageal Reflux

Japan
Harlachinger Krebshilfe e.V.
Deutsche AIDS Gesellschaft e.V.

Unknown

Prospective Study on HIV-related Hodgkin Lymphoma

HIV-associated Hodgkin Lymphoma

Germany
General Public Hospital Zell am See

Unknown

Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD

Gastroesophageal Reflux Disease

Austria
Ahn-Gook Pharmaceuticals Co.,Ltd

Completed

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease (AGSPT)

Gastroesophageal Reflux Disease

Korea, Republic of

Search clinical trials for: GERD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations